Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents

首圖 SAN DIEGO & DUBLIN — (BUSINESS WIRE) — Crown Bioscience, Inc, a JSR Life Sciences Company, and ERS Genomics Limited (『ERS』) have signed a global license agreement for access to the fou…


發佈留言